Long-term Use of Golimumab in Daily Practice for Patients with Rheumatoid Arthritis

OBJECTIVE: To evaluate the effectiveness and drug retention rate of golimumab (GLM) for long-term use in daily practice for patients with rheumatoid arthritis (RA). METHODS: Patients with RA who started GLM therapy with a minimum follow-up period of 52 weeks were included. The patients were divided...

Descripción completa

Detalles Bibliográficos
Autores principales: Nemoto, Tetsuya, Ito, Satoshi, Kobayashi, Daisuke, Takai, Chinatsu, Sakai, Syunsuke, Kurosawa, Youichi, Hasegawa, Eriko, Okabayashi, Ryo, Abe, Asami, Otani, Hiroshi, Lee, Hyunho, Murasawa, Akira, Narita, Ichiei, Nakazono, Kiyoshi, Toyoshima, Yoich, Inagaki, Katunori, Ishikawa, Hajime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170247/
https://www.ncbi.nlm.nih.gov/pubmed/33250460
http://dx.doi.org/10.2169/internalmedicine.5381-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170247/
https://www.ncbi.nlm.nih.gov/pubmed/33250460
http://dx.doi.org/10.2169/internalmedicine.5381-20

Ejemplares similares